Search results
May 4, 2024 · A birth defect, also known as a congenital disorder, is an abnormal condition that is present at birth regardless of its cause. [3] . Birth defects may result in disabilities that may be physical, intellectual, or developmental. [3] . The disabilities can range from mild to severe. [7] .
- 628,000 (2015)
3 days ago · Congenital rubella syndrome is the most convincing environmental cause of autism. Infection-associated immunological events in early pregnancy may affect neural development more than infections in late pregnancy, not only for autism, but also for psychiatric disorders of presumed neurodevelopmental origin, notably schizophrenia .
4 days ago · There are a number of effective preventative strategies, including: immunization against rubella to prevent congenital rubella syndrome, immunization against H. influenza and S. pneumoniae to reduce cases of meningitis, and avoiding or protecting against excessive noise exposure.
- Decreased ability to hear
Apr 16, 2024 · Launched in 2001, as the Measles and Rubella Initiative, the revitalized Partnership is committed to ensuring no child dies from measles or is born with congenital rubella syndrome. The Partnership helps countries plan, fund and measure efforts to permanently stop measles and rubella . References. 1.
Apr 16, 2024 · Rubella is a common childhood illness caused by a virus, although it can affect people of any age. The illness spreads from person to person through coughs and sneezes. Symptoms are often mild and may include low fever, swollen glands, rash, and red bumps on the roof of the mouth.
Apr 25, 2024 · Rubella infection is typically mild or asymptomatic except when infection occurs during pregnancy. Infection in early pregnancy can cause miscarriage, stillbirth, or congenital rubella syndrome. Only individuals that are still susceptible to rubella infection during child-bearing age are vulnerable ...
Apr 29, 2024 · Background. Microneedle patches (MNPs) have been ranked as the highest global priority innovation for overcoming immunisation barriers in low-income and middle-income countries. This trial aimed to provide the first data on the tolerability, safety, and immunogenicity of a measles and rubella vaccine (MRV)-MNP in children. Methods.
